Dr. Gahremanpour was born in Shiraz, Iran and he graduated as an MD from Shiraz University School of Medicine. He practiced in the Coronary Care Unit as a Hospitalist in Shiraz where he gained extensive experience in the diagnosis and medical management of Cardiovascular Diseases. He moved to the United States in pursuit of advanced cardiac training and to achieve his goals as an avid researcher. He completed his Internal Medicine Residency from Pennsylvania State University College of Medicine in Hershey Pennsylvania and his Cardiology Felllowship from the prestigious Texas Heart Institute affiliated with Baylor college of Medicine. He continued training in Interventional Cardiology at Texas Heart Institute under the eminent Dr. David Fish and is experienced in percutaneous coronary and peripheral arterial interventions as well as Transcatheter Aortic Valve Replacement (TAVR).
Dr. Gahremanpour has been part of cutting edge medicine and has published many papers in peer reviewed journals. He has done a Research Fellowship under Dr. Nabil Dib, a pioneer physician in the field of regenerative medicine at the Arizona Heart Institute in Phoenix, Arizona. With the guidance of his renowned mentor, Dr. Gahremanpour studied the role of stem cell and gene therapy in restoring cardiac function after myocardial infarction. That project led to the FDA approval for the first catheter-based clinical trial of using autologous skeletal myoblasts to treat ischemic cardiomyopathy in the United States. His passion for regenerative medicine led him to join the Texas Heart Institute at St. Luke’s Hospital in Houston, one the seven centers nationwide which are part of the National Institute of Health sponsored Cardiovascular Cell Therapy Research Network (CCTRN). At the Texas Heart Institute Dr. Gahremanpour completed a Research Fellowship mentored by the world famous Dr. Emerson Perin. He conducted translational research projects in the application of stem cells and hepatocyte growth factor in restoring cardiac function in the animal model of myocardial infarction. He has participated in numerous National Institute of Health sponsored clinical trials and served as Co-Investigator in American Heart Association and National Institute of Health research grants.
With his extensive training as an Interventional Cardiologist and his well published contributions to medical science Dr. Gahremanpour is a great addition to the expertise to Northwest Houston Heart Center. He is available daily for appointments including same day appointments in office.